Search Results 1941-1950 of 19664 for hemoglobin

  1. Phase II Single-arm Study of Tepotinib Combined with Cetuximab - Mayo Clinic

    ... hemoglobin ≥ 8.5 g/dL. Adequate hepatic function defined by a total bilirubin level ≤ 1.5 × upper limit of normal (ULN), AST ≤ 3 × ULN, and ALT ≤ 3 ...

  2. A Study to Analyze CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma - Mayo Clinic

    Hemoglobin concentration ≥ 9 g/dL;; White blood cells ≥ 2000/mm^3. Liver function: Total bilirubin ≤ 1.5 times the upper limit of normal (ULN) with the ...

  3. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients - Mayo Clinic

    Hemoglobin concentration <9 g/dL at Screening. 12. Subjects treated with an IV or SC prostacyclin pathway agent (eg, epoprostenol, treprostinil, or iloprost) ...

  4. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  5. Publications - Lance A. Williams, III, M.D. - Mayo Clinic

    ... hemoglobin Evans with secondary methemoglobinemia. J Clin Apher. 2023 Dec; 38 (6):755-759 Epub 2023 Sept 04. View PubMed; Williams LA 3rd, Thiele BA, Kinard T ...

  6. A Study to Evaluate Olaparib and Temozolomide in Treating Patients With Advanced, Metastatic, or Unresectable Uterine Leiomyosarcoma - Mayo Clinic

    Hemoglobin ≥ 8 g/dL (without transfusion of packed red blood cells within the past 14 days) (measured within 14 days prior to administration of study ...

  7. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

    Hemoglobin >= 9 g/dL; Thyroid stimulating hormone (TSH) < lower limit of normal (LLN) (patients not able to tolerate TSH suppression can be granted an ...

  8. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Hemoglobin > 9 g/dL, transfusion permitted; Total bilirubin < 1.5 x upper limit of normal (ULN) (or < 3 x ULN for subjects with Gilbert's syndrome) ...

  9. A Study to Determine Recommended Dose, Regimen and Evaluate the Safety and Preliminary Effectiveness of CC-92480 in Combination With Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) - Mayo Clinic

    Hemoglobin < 8 g/dL (< 4.9 mmol/L);; Creatinine clearance (CrCl) < 45 mL/min (< 30 mL/min for Cohort G);; Corrected serum calcium > 13.5 mg/dL (> 3.4 mmol/L); ...

  10. A Study to Assess the Safety and Dose Escalation of Pegtomarginase (PT01) for Subjects with Advanced Malignancies - Mayo Clinic

    Hemoglobin ≥ 90 g/L. Adequate liver function as demonstrated by: Serum bilirubin < 2 × the upper limit of normal (ULN);; Aspartate transaminase (AST) and ...